ADC Therapeutics (ADCT) Debt Ratio (2020 - 2026)

ADC Therapeutics has disclosed Debt Ratio across 7 years of filings, most recently posting 0.4 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.4, down 4.96% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.4 (down 4.96% YoY), and the FY2025 annual result was 0.36, up 1.23% from the prior year.
• Debt Ratio came in at 0.4 for Q1 2026 at ADC Therapeutics, up from 0.36 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.42 in Q1 2025 to a low of 0.22 in Q4 2022.
• The 5-year median for Debt Ratio is 0.36 (2025), against an average of 0.35.
• Across the five-year window, Debt Ratio jumped 58.49% in 2022 and slipped 4.96% in 2026, its largest moves.
• ADC Therapeutics' Debt Ratio stood at 0.22 in 2022, then surged by 42.12% to 0.32 in 2023, then advanced by 11.1% to 0.35 in 2024, then rose by 1.23% to 0.36 in 2025, then increased by 11.08% to 0.4 in 2026.
• The last three Debt Ratio figures came in at 0.4 (Q1 2026), 0.36 (Q4 2025), and 0.4 (Q3 2025), per Business Quant data.